Clinical Trial Results: Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial results for the SUPERNOVA study and its sub-study across Phase 2 and Phase 3 have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Snippet

Sponsor: AstraZeneca | Conditions: COVID-19, SARS-CoV-2 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-06-18